In the US, Requip (ropinirole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder and Restless Legs Syndrome.
US matches:
- Requip
- Requip XL Extended-Release Tablets
- Requip Starter Kit
- Requip XL
- Requip-XL
UK matches:
- Requip Tablets (SPC)
- Requip XL prolonged-release tablets (SPC)
Ingredient matches for Requip
Ropinirole is reported as an ingredient of Requip in the following countries:
- Slovenia
- Taiwan
- Tunisia
Ropinirole hydrochloride (a derivative of Ropinirole) is reported as an ingredient of Requip in the following countries:
- Argentina
- Austria
- Belgium
- Brazil
- Bulgaria
- Canada
- Chile
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Japan
- Latvia
- Luxembourg
- Malaysia
- Malta
- Netherlands
- New Zealand
- Norway
- Oman
- Poland
- Portugal
- Romania
- Serbia
- Singapore
- Slovakia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Kingdom
- United States
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.